Liver fibrosis improvement in chronic hepatitis C after direct acting-antivirals is accompanied by reduced profibrogenic biomarkers-a role for MMP-9/TIMP-1

Título:

Liver fibrosis improvement in chronic hepatitis C after direct acting-antivirals is accompanied by reduced profibrogenic biomarkers-a role for MMP-9/TIMP-1

Autor:

Andréa Alice da Silva

Ano:

2020

DOI:

10.1016/j.dld.2020.05.004

Revista:

Digestive and Liver Disease

ISSN:

15908658

Tags:

metaloproteases

Hepatite C crônica

terapia com DAA

Idioma:

Inglês

Buscar essa publicação no Google Acadêmico

Publicações com a mesma autoria

Óxido Nítrico: produção e métodos de dosagem

Infecção pelo Vírus Zika - Revisão da Literatura

Adverse effects of direct acting antiviral-based regimens in chronic hepatitis C patients: a Brazilian experience

Intercellular Adhesion Molecule 1 Deficiency Leads to Impaired Recruitment of T Lymphocytes and Enhanced Host Susceptibility to Infection with Trypanosoma cruzi

Timeline analysis of IgA and IgG levels in Covid-19 hospitalized patients according to the clinical outcome

Essential role of VLA-4/VCAM-1 pathway in the establishment of CD8+ T-cell-mediated Trypanosoma cruzi-elicited meningoencephalitis

Tumor Necrosis Factor Is a Therapeutic Target for Immunological Unbalance and Cardiac Abnormalities in Chronic Experimental Chagas? Heart Disease

Interferon-Gamma Promotes Infection of Astrocytes by Trypanosoma cruzi

BK polyomavirus nephropathy in two kidney transplant patients with distinct diagnostic strategies for BK virus and similar clinical outcomes: two case reports

Restoring Inflammatory Mediator Balance after Sofosbuvir-Induced Viral Clearance in Patients with Chronic Hepatitis C